The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Sep 2017 11:44

RNS Number : 5164Q
Interserve PLC
12 September 2017
 

12 September 2017

INTERSERVE PLC ("The Company")

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRs")

Restricted Stock Award

The following individual notification made under article 19.1 of the Market Abuse Regulation ('MAR') relates to awards promised upon recruitment on behalf of a PDMR. This announcement is made in accordance with Article 19.3 of MAR.

On 11 September 2017, Debra Jayne White, Chief Executive, received restricted stock awards over fully-paid ordinary shares of 10 pence each in the capital of the Company ("Shares") in order to compensate her for forfeited awards from previous employment. Consistent with the Company's remuneration policy, the restricted stock awards replicate, as far as practicable, the terms (including performance conditions where relevant) and value of awards forfeited by Ms White in agreeing to join the Company. Where awards forfeited were subject to performance conditions, these awards have been exchanged into Shares in the Company but with the original performance conditions continuing to apply (i.e. these parts of the restricted stock awards will only vest to the extent that the relevant performance conditions are met, further details of which are set out in the Report & Accounts of Ms White's previous employer). No consideration was paid for the grant of these awards.

The restricted stock awards (which are over 1,897,899 Shares in total) will vest, subject to the rules of the Restricted Stock Contract and to Ms White's on-going employment with the Company, in the following tranches on the vesting dates set out below. Part of the restricted stock award over Shares will be subject to performance conditions as noted above. Further details of the awards, including the associated performance conditions, will be set out in the 2017 Directors' Remuneration Report.

Tranche

Total number of Shares under award granted

Vesting date

Performance condition

1

481,158

11 March 2018

N/A

2

267,310

27 April 2019

N/A

3

133,655

27 April 2019

Yes

4

133,655

27 April 2019

Yes

5

133,655

9 September 2019

N/A

6

66,827

9 September 2019

Yes

7

66,827

9 September 2019

Yes

8

307,406

27 April 2020

N/A

9

153,703

27 April 2020

Yes

10

153,703

27 April 2020

Yes

 

 

1.1

Notification and public disclosure of transactions by PDMRs and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Debra Jayne White

2.

Reason for the notification

a)

Position/status

 Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 INTERSERVE PLC

b)

LEI

 LEI: 549300MVYY4EZCRFHZ09

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

 ORDINARY SHARES OF 10 PENCE EACH

 GB0001528156

b)

Nature of transaction

Grant of a restricted stock award over ordinary shares in the Company, for nil-consideration, under a Restricted Stock Contract. This award is a buy-out incentive granted in accordance with the Company's existing remuneration policy in respect of incentive arrangements put in place by Ms White's previous employer that were lost on recruitment to INTERSERVE PLC. 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Consideration

 

 1,897,899 shares

d)

Aggregated information

- Aggregated volume

- Price

 

Nil Consideration

 

 

 1,897,899 shares

e)

Date of the transaction

11 September 2017

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

 

Interserve Performance Share Plan 2015 (the "Plan")

 

In addition to the aforementioned and pursuant to article 19 of regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation or "MAR"), the Company further announces that on 11 September 2017 Ms White was granted an Award under the Plan in the form of nil-cost options, to acquire Shares, up to maximum of 599,778 (the "PSP Award").

 

The price used to calculate the maximum number of Shares under the Plan was 162.56p, being the average closing price on 5,6,7 and 8 September 2017 of the Company's shares on the main market of the London Stock Exchange. The PSP Award will normally vest on or after the third anniversary of the date of grant, subject to the fulfilment of certain performance conditions based on earnings per share and total shareholder return and is subject to recovery & withholding provisions and a two-year post-vesting holding period. No consideration is payable on the grant or the vesting of the Award, which will lapse if not exercised within two years of vesting.

 

 

12 September 2017

 

Trevor Bradbury

Group Secretary

Tel: 0118 932 0123

 

 

 Notification and public disclosure of transactions by PDMR and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Debra Jayne White

2.

Reason for the notification

a)

Position/status

 Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 INTERSERVE PLC

b)

LEI

 LEI: 549300MVYY4EZCRFHZ09

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

 ORDINARY SHARES OF 10 PENCE EACH

 GB0001528156

b)

Nature of transaction

 

 

 

 

 

 Nil cost options granted on 11 September 2017 pursuant to the Interserve Performance Share Plan 2015. 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil Consideration

 

 599,778 shares

d)

Aggregated information

- Aggregated volume

- Price

 

 

Nil Consideration

 

 

 599,778 shares

e)

Date of the transaction

 11 September 2017

f)

Place of the transaction

 Outside a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLTMMTMBIBBBR
Date   Source Headline
15th Mar 20196:27 pmRNSInterserve
15th Mar 20195:56 pmRNSSuccessful completion of sale of the Group
15th Mar 20192:47 pmRNSHolding(s) in Company
15th Mar 20192:01 pmRNSParent Company Administration
15th Mar 201912:33 pmRNSResult of General Meeting
14th Mar 201911:41 amRNSTotal Voting Rights and Warrant Update
14th Mar 20199:18 amRNSDirector/PDMR Shareholding
12th Mar 20198:30 amRNSBlock Listing Application
11th Mar 20195:27 pmRNSResponse to media reports re Deleveraging Plan
5th Mar 201912:56 pmRNSResponse to proposal Coltrane Asset Management L.P
4th Mar 20196:03 pmRNSUpdate on Coltrane Asset Management L.P Proposal
28th Feb 20199:58 amRNSPublication of a Prospectus
27th Feb 20199:05 amRNSDeleveraging Plan details and launch
27th Feb 20198:58 amRNSFull Year Results 2018
26th Feb 20194:17 pmRNSNotice of Requisition General Meeting
22nd Feb 20193:54 pmRNSHolding(s) in Company
22nd Feb 20193:50 pmRNSUpdate on Deleveraging Plan
20th Feb 20199:56 amRNSHolding(s) in Company
19th Feb 201910:13 amRNSHolding(s) in Company
13th Feb 20194:25 pmRNSDirector/PDMR Shareholding
12th Feb 20197:00 amRNSDirectorate Change
6th Feb 20197:10 amRNSStatement re Shareholder Requisition
6th Feb 20197:00 amRNSStatement re Deleveraging Plan
24th Jan 201912:07 pmRNSSecond Price Monitoring Extn
24th Jan 201912:02 pmRNSPrice Monitoring Extension
16th Jan 20191:14 pmRNSDirector/PDMR Shareholding
14th Jan 20194:41 pmRNSSecond Price Monitoring Extn
14th Jan 20194:36 pmRNSPrice Monitoring Extension
2nd Jan 201912:30 pmRNSHolding(s) in Company
2nd Jan 20197:00 amRNSBlock listing Interim Review
28th Dec 20184:20 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSProgress on Deleveraging Plan
17th Dec 20182:52 pmRNSDirector/PDMR Shareholding
10th Dec 20189:30 amRNSInterserve Awarded £25m Contract.
10th Dec 20187:00 amRNSDELEVERAGING PLAN
29th Nov 20182:30 pmRNSHolding(s) in Company
28th Nov 201810:50 amRNSHolding(s) in Company
27th Nov 20183:59 pmRNSHolding(s) in Company
23rd Nov 20182:07 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNS3rd Quarter Update
16th Nov 20184:12 pmRNSHolding(s) in Company
16th Nov 20184:09 pmRNSHolding(s) in Company
13th Nov 20182:50 pmRNSStatement following recent press coverage
13th Nov 201811:00 amRNSDirector/PDMR Shareholding
23rd Oct 201811:03 amRNSHolding(s) in Company
22nd Oct 20184:27 pmRNSHolding(s) in Company
17th Oct 20189:04 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSSALE OF ACCESS AND HARD SERVICES BUSINESS
1st Oct 20189:27 amRNSHolding(s) in Company
14th Sep 20189:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.